Francis Mussai

2.1k total citations
40 papers, 1.4k citations indexed

About

Francis Mussai is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Francis Mussai has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Francis Mussai's work include Cancer Research and Treatments (7 papers), Neuroblastoma Research and Treatments (7 papers) and Immune Cell Function and Interaction (7 papers). Francis Mussai is often cited by papers focused on Cancer Research and Treatments (7 papers), Neuroblastoma Research and Treatments (7 papers) and Immune Cell Function and Interaction (7 papers). Francis Mussai collaborates with scholars based in United Kingdom, United States and Switzerland. Francis Mussai's co-authors include Carmela De Santo, Sarah Booth, Livingstone Fultang, Vincenzo Cerundolo, Paresh Vyas, Rosanna M. McEwen-Smith, Amrana Qureshi, Francesco Dazzi, Lynn Quek and Issa Abu‐Dayyeh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Francis Mussai

39 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francis Mussai United Kingdom	18	591	510	438	296	284	40	1.4k
Denis M. Schewe Germany	18	308 0.5×	632 1.2×	653 1.5×	242 0.8×	316 1.1×	54	1.6k
Enkhtsetseg Purev United States	21	308 0.5×	755 1.5×	768 1.8×	551 1.9×	184 0.6×	55	1.6k
Bellinda A. Bladergroen Netherlands	17	471 0.8×	200 0.4×	399 0.9×	111 0.4×	156 0.5×	19	1.0k
Brandy Perkins United States	13	440 0.7×	369 0.7×	578 1.3×	497 1.7×	138 0.5×	18	1.4k
Falguni Parikh India	13	425 0.7×	747 1.5×	474 1.1×	25 0.1×	327 1.2×	50	1.3k
Jérôme Paggetti Luxembourg	18	691 1.2×	399 0.8×	1.2k 2.7×	142 0.5×	694 2.4×	38	1.9k
Toshihiko Kuroda Japan	18	213 0.4×	609 1.2×	711 1.6×	34 0.1×	149 0.5×	40	1.5k
LH Shapiro United States	8	178 0.3×	466 0.9×	822 1.9×	224 0.8×	193 0.7×	9	1.3k
Heather Tillman United States	20	419 0.7×	297 0.6×	580 1.3×	227 0.8×	129 0.5×	37	1.2k
Raphaël F. Rousseau United States	24	599 1.0×	758 1.5×	708 1.6×	110 0.4×	269 0.9×	56	1.8k

Countries citing papers authored by Francis Mussai

Since Specialization

Citations

This map shows the geographic impact of Francis Mussai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis Mussai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis Mussai more than expected).

Fields of papers citing papers by Francis Mussai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis Mussai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis Mussai. The network helps show where Francis Mussai may publish in the future.

Co-authorship network of co-authors of Francis Mussai

This figure shows the co-authorship network connecting the top 25 collaborators of Francis Mussai. A scholar is included among the top collaborators of Francis Mussai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis Mussai. Francis Mussai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Köster, Jan, et al.. (2025). The immune landscape of pediatric (extra)cranial solid tumors: A systematic review and integration of immunohistochemistry and single-cell RNA sequencing data. European Journal of Cancer. 228. 115708–115708. 1 indexed citations

Doz, François, Michela Casanova, Karsten Nysom, et al.. (2025). Alectinib in children and adolescents with solid or CNS tumors harboring ALK-fusions: A data update from the iMATRIX alectinib phase I/II open-label, multi-center study.. Journal of Clinical Oncology. 43(16_suppl). 10004–10004.

Doz, François, Michela Casanova, Kyung‐Nam Koh, et al.. (2024). Abstract CT039: Alectinib in children and adolescents with solid or CNS tumors harboring ALK-fusions: Data from the iMATRIX Alectinib Phase I/II open-label, multi-center study. Cancer Research. 84(7_Supplement). CT039–CT039. 1 indexed citations

Kalkman, Eric R., Mary T. Scott, Karen Dunn, et al.. (2023). Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells. EMBO Reports. 24(10). e56279–e56279. 5 indexed citations

Panetti, Silvia, Livingstone Fultang, Sarah Booth, et al.. (2022). Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment. Blood Advances. 7(9). 1754–1761. 28 indexed citations

Mussai, Francis, Carmela De Santo, Paul Cheng, et al.. (2022). A randomised evaluation of low‐dose Ara‐C plus pegylated recombinant arginase BCT‐100 versus low dose Ara‐C in older unfit patients with acute myeloid leukaemia: Results from the LI‐1 trial. British Journal of Haematology. 200(5). 573–578. 7 indexed citations

Fultang, Livingstone, Matthew Pugh, William E. Jenkinson, et al.. (2022). G‐CSF induces CD15⁺ CD14⁺ cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironment. Clinical & Translational Immunology. 11(5). e1395–e1395. 6 indexed citations

Storer, Lisa, et al.. (2022). Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion. BioMed Research International. 2022(1). 9008685–9008685. 4 indexed citations

Hejmadi, Rahul, et al.. (2021). TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer. Cancer Immunology Immunotherapy. 71(7). 1583–1596. 18 indexed citations

10.

Cheng, Paul, Angela M. Liu, Alberto Bessudo, & Francis Mussai. (2021). Safety, PK/PD and preliminary anti-tumor activities of pegylated recombinant human arginase 1 (BCT-100) in patients with advanced arginine auxotrophic tumors. Investigational New Drugs. 39(6). 1633–1640. 17 indexed citations

11.

Collins, Paul J., Christopher P. Fox, Hayden Pearce, et al.. (2020). Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells. Blood. 137(2). 203–215. 26 indexed citations

12.

Cader, Fathima Zumla, Isabel Colmenero, & Francis Mussai. (2019). Hemophagocytic Lymphohistiocytosis Associated With 2 Cases of Pediatric Lymphocyte-depleted Classic Hodgkin Lymphoma. Journal of Pediatric Hematology/Oncology. 41(5). e341–e345. 2 indexed citations

13.

Khanna, Swati, Francis Mussai, Anish Thomas, et al.. (2018). Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients. Clinical Cancer Research. 24(12). 2859–2872. 43 indexed citations

14.

Shaheen, Najma & Francis Mussai. (2018). Enteroviral Encephalitis in a Child With CNS Relapse of Burkitt Leukemia Treated With Rituximab. Journal of Pediatric Hematology/Oncology. 41(1). e27–e29. 7 indexed citations

15.

Dandapani, Madhumita, et al.. (2017). Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies. Oncotarget. 8(38). 63506–63517. 21 indexed citations

16.

Mussai, Francis, Sharon A. Egan, Stuart Hunter, et al.. (2015). Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity. Cancer Research. 75(15). 3043–3053. 84 indexed citations

17.

Santo, Carmela De & Francis Mussai. (2015). Neuroblastoma arginine addiction subverts the anticancer immune response. OncoImmunology. 5(2). e1078967–e1078967. 2 indexed citations

18.

Mussai, Francis, Carmela De Santo, & Vincenzo Cerundolo. (2012). Interaction Between Invariant NKT Cells and Myeloid-derived Suppressor Cells in Cancer Patients. Journal of Immunotherapy. 35(6). 449–459. 27 indexed citations

19.

Mussai, Francis, Dario Campana, Deepa Bhojwani, et al.. (2010). Cytotoxicity of the anti‐CD22 immunotoxin HA22 (CAT‐8015) against paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 150(3). 352–358. 61 indexed citations

20.

Richards, Toby, Francis Mussai, Jane Phillips‐Hughes, Raman Uberoi, & Phil Boardman. (2007). Thrombin Injection for Acute Hemorrhage Following Angiography. CardioVascular and Interventional Radiology. 30(4). 786–788. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact